
Kathleen Otto-Rosenblum, CEO of BioNTX
BioNTX, a prominent biotechnology and healthcare innovation organization in North Texas, has announced that their premier event of the year for bioscience and healthcare innovation leaders throughout the region: iC³. The 10th annual iC³ Summit is expected to have more than 1,000 industry professionals, researchers, entrepreneurs, and investors, marking its largest attendance to date. The event's formula, "Innovation = Capital × Collaboration × Commercialization," underscores its commitment to catalyzing breakthroughs through strategic partnerships and investments.